Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 9/20 | 0.57 |
| ▸ | CREBBP | Q92793 | 9/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 4/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 4/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20715625 | 0.87 | CREBBP (0.54) | BRD4CREBBPMAOAMAOBEP300 | |
| SCHEMBL434946 | 0.81 | BRD4 (0.53) | BRD4CREBBPEP300TP53 | |
| SCHEMBL28978985 | 0.80 | CREBBP (0.50) | BRD4CREBBPMAOAMAOBALDH1A1 | |
| SCHEMBL30293263 | 0.80 | CREBBP (0.50) | BRD4CREBBPMAOAMAOBALDH1A1 | |
| SCHEMBL7264599 | 0.80 | KMT2A (0.45) | BRD4PDE3BPDE3ATP53 | |
| SCHEMBL17479629 | 0.80 | CA9 (0.44) | BRD4CREBBPALDH1A1EP300PDE3B | |
| SCHEMBL9376059 | 0.78 | BRD4 (0.47) | BRD4CREBBPALDH1A1EP300 | |
| SCHEMBL10285196 | 0.78 | MAOA (0.55) | BRD4CREBBPMAOAMAOBALDH1A1 | |
| SCHEMBL21374146 | 0.78 | BRD4 (0.44) | BRD4CREBBPALDH1A1EP300PDE3B | |
| SCHEMBL30293231 | 0.78 | MAOA (0.55) | BRD4CREBBPMAOAMAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109988093-B | Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine | 广东东阳光药业有限公司 | 2023-04-07 | — | — | CN | disclosed |